<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>Vioxx Problems Hidden by Merck</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2004/11/01/Vioxx-Problems-Hidden-by-Merck.aspx</link><description>After all the smoke cleared and Vioxx was off the market, the inevitable lawsuits were filed against its corporate parent, Merck and Co. According to reports in today's Wall Street Journal, the concerns many people had about Vioxx were more than justified</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>